PDRX vs MSFT: Which Stock is Better?
Side-by-side comparison of Pd-Rx Pharmaceutical and Microsoft Corp in 2026
PDRX
Pd-Rx Pharmaceutical
$3.35
MSFT
Microsoft Corp
$417.51
Key Metrics Comparison
| Metric | PDRX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $5.75M | N/A | PDRX |
| P/E Ratio | 3.10 | 26.59 | PDRX |
| EPS (TTM) | $1.08 | $15.97 | MSFT |
| Revenue Growth | -0.0% | 0.2% | MSFT |
| Gross Margin | 29.6% | 68.6% | MSFT |
Analyze PDRX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PDRX or MSFT a better investment?
Comparing PDRX and MSFT: Pd-Rx Pharmaceutical has a market cap of $5.75M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PDRX and MSFT?
PDRX (Pd-Rx Pharmaceutical) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PDRX or MSFT?
Based on P/E ratios, PDRX trades at a lower multiple (3.1x vs 26.6x).
Which is growing faster: PDRX or MSFT?
MSFT has higher revenue growth at 0.2% vs -0.0% for PDRX.
Which company is more profitable: PDRX or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 29.6% for PDRX.
Which is the larger company: PDRX or MSFT?
Pd-Rx Pharmaceutical (PDRX) is larger with a market cap of $5.75M compared to N/A for MSFT.
Should I buy PDRX or MSFT in 2026?
Both PDRX and MSFT have investment merit. PDRX trades at $3.35 while MSFT trades at $417.51. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PDRX and MSFT stock?
Key differences: Market Cap ($5.75M vs N/A), P/E Ratio (3.1x vs 26.6x), Revenue Growth (-0.0% vs 0.2%), Gross Margin (29.6% vs 68.6%).